'Over the next five years,' announced Dr. Carol Locke, a graduate of Harvard Medical School 'we will see Omega-3 fatty acids become a foundation of health.'

Dr. Locke is also the creator of the brand of omega-3 fatty acids called OmegaBrite, which was recently shown to be an effective treatment in minimizing manic episodes of children with bipolar disorder.

A recent study, published by researchers at Harvard's Massachusetts General Hospital, shows that OmegaBrite with its high EPA Omega-3 content is effective therapy in reducing manic episodes for children with bipolar disorder. The research indicated a 30% reduction in manic episodes in those children with bipolar disorder who were between the ages of six and 17years of age.

The results were reported in the journal European Neuropsychopharmacology in February 2007. The study was funded by a grant from the Stanley Foundation.

The results of the study found that the administration of these supplements reduced the participants Young Mania Rating Scale Scores or YMRS by 30 percent. YMRS is the standard rating scale for children with bipolar disorder. This reduction is very similar to the effectiveness of several prescription drugs on the market for bipolar disorder. Omega-3, though, doesn't have the side effects associated with the drugs. Some of the side effects include acne, weight gain and diabetes.

This study only adds weight to the value of Omega-3 fatty acids. Several years ago researchers study the effects of this supplement on adults with bipolar disorder. The results were also favorable.

Omega-3 is not just an important supplement for those with bipolar disorder, though. The body is in need of a balance of Omega-6 and Omega-3, according to the health experts. If the proper ratio is not found in the body, your system can react with an overall inflammatory response. Chronic health conditions could develop, including depression, cardiac disease, cancer, dementia, rheumatoid arthritis and asthma.

The Harvard study on bipolar disorder in children 'demonstrates the power of the Omega-3 EPA on mood . . .' Dr. Locke said.

It should be noted however that no individual should alter or quit taking his medication for bipolar disorder without first consulting his physician. While the study looks promising as a future treatment, only your personal physician can make the decisions about the specifics of the symptoms of your disorder.